Susac Syndrome Treated with Subcutaneous Immunoglobulin

Publisher： Karger

E-ISSN： 1421-9913|71|1-2|89-92

ISSN： 0014-3022

Source： European Neurology, Vol.71, Iss.1-2, 2013-12, pp. : 89-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Susac's syndrome or retinocochleocerebral vasculopathy: a misdiagnosed and overlooked disorder

By Marie I.   Guegan-Massardier E.   Levesque H.   Favennec L.   Cailleux N.   Courtois H.  

European Journal of Internal Medicine, Vol. 11, Iss. 2, 2000-04 ,pp. : 108-111

Elsevier

Access to resources Recommend Favorite

Recurrence of Susac Syndrome following 23 Years of Remission

By  

Case Reports in Neurology, Vol. 6, Iss. 2, 2014-05 ,pp. : 171-175

Karger

Access to resources Recommend Favorite

Subcutaneous immunoglobulin administration: an alternative to intravenous infusion as adjuvant treatment for dermatomyositis?

By Schleinitz Nicolas   Jean Estelle   Benarous Lucas   Mazodier Karin   Figarella-Branger Dominique   Bernit Emmanuelle   Veit Véronique   Kaplanski Gilles   Harle Jean-Robert  

Clinical Rheumatology, Vol. 27, Iss. 8, 2008-08 ,pp. : 1067-1068

Springer Publishing Company

Access to resources Recommend Favorite

Subcutaneous Immunoglobulin Use in Inclusion Body Myositis: A Review of 6 Cases

By  

Case Reports in Neurology, Vol. 7, Iss. 3, 2015-11 ,pp. : 227-232

Karger

Access to resources Recommend Favorite

Home Therapy with Subcutaneous Anti-Immunoglobulin-E Antibody Omalizumab in 25 Patients with Immunoglobulin-E-Mediated (Allergic) Asthma

By Liebhaber Myron   Dyer Zeb  

Journal of Asthma, Vol. 44, Iss. 3, 2007-04 ,pp. : 195-196

Informa Healthcare

Access to resources Recommend Favorite